GBT Stock: Why Pfizer's $5.4 Billion Takeover Is 'Mutually Beneficial'

Pfizer inked a $5.4 billion deal to buy Global Blood Therapeutics. The deal could add a peak $3 billion in worldwide sales to Pfizer's coffers. GBT's approved treatment for sickle cell disease,...

GBT Stock: Why Pfizer's $5.4 Billion Takeover Is 'Mutually Beneficial'

Pfizer inked a $5.4 billion deal to buy Global Blood Therapeutics. The deal could add a peak $3 billion in worldwide sales to Pfizer's coffers. GBT's approved treatment for sickle cell disease,...

BioNTech, Pfizer sue CureVac in U.S. over COVID-19 vaccine patent claims

By Ludwig Burger FRANKFURT - COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer (NYSE:PFE) have filed a complaint with the U.S. District Court in Massachusetts, seeking a...

Signs point to biotech M&A heating up, Wells Fargo says. Here's where to look

The pace of biotech deals is likely to pick up, but investors should think about smaller targets, says Wells Fargo analyst Mohit Bansal. The analyst called out both enticing valuations for small-...

Biotech is in ‘a Category 5 storm, the same as energy in 2020’

More than 25% of small biotech companies have stock-market capitalizations that are smaller than how much they have in cash. That 25% is the highest in 15 years — higher than even during the...

UC Berkeley loses CRISPR patent case

MIT and Harvard’s Broad Institute was the first to apply the gene-editing tool CRISPR to human cells, the US Patent and Trademark Office says. The decision stymies years of efforts from the...

FDA Raises Concerns About China-Developed Drugs

U.S. regulators are poised to tap the brakes on approving dozens of cancer drugs and other new medicines developed in China. The regulators have expressed concerns about the quality of studies....

Bowing to pressure, JP Morgan says health care conference will be virtual

The J.P. Morgan Healthcare Conference, biotech's biggest annual conference, will be virtual. Big-name drug companies balked at an in-person meeting amid escalating cases of Covid-19. Moderna,...

One-Stop Business News, backed by Mark Cuban. Free to Use →